Research map: From “bridging specialties” to “owning the patient”: rethinking accountability in Cardiovascular-Kidney-Metabolic syndrome care

Back to the article

Papers in this map

  1. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association · Chiadi E. Ndumele · 2023 · 2076 citations · Cited by this paper
  2. Beta-blockers after myocardial infarction: time to change the guidelines · 2026 · Related
  3. Medical Treatments in Patients With Ambulatory Heart Failure: First Data From the BRING-UP-3 Heart Failure Study · Fabrizio Giovanni Oliva · 2025 · 11 citations · Cited by this paper
  4. Why does research integrity affect us all? · 2026 · Related
  5. Implementing sodium–glucose co-transporter 2 inhibitors in cardiovascular–kidney–metabolic syndrome: a multidisciplinary expert perspective · Angelo Avogaro · 2026 · 4 citations · Cited by this paper
  6. Aspirin may take a back row seat for non-ST-segment elevation acute coronary syndrome after percutaneous coronary intervention · 2026 · Related
  7. Reporting data from meta-analysis: snapshot of a moving target · Yousif Ahmad · 2021 · 3 citations · Cited by this paper
  8. Innovation and constraints in cardiovascular pharmacotherapy · 2026 · Related
  9. Why cardio-rheumatology? · 2026 · Related
  10. VESALIUS keeps revolutionizing medicine: the case of evolocumab in primary prevention · 2025 · Related
  11. Effect of beta blockers in acute and chronic coronary syndromes without reduced ejection fraction: a landmark analysis from the REBOOT trial · 2026 · Related
  12. Real-world evidence of finerenone in Type 2 diabetes: addressing confounding and follow-up duration · 2025 · Related
  13. Different aspects of myocardial intervention and pharmacological treatment · 2026 · Related

Source: OpenAlex (CC0)